Jason R.  Kelly net worth and biography

Jason Kelly Biography and Net Worth

Insider of Ginkgo Bioworks
Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. He has served as a member of our board of directors since Ginkgo’s founding in 2008. He has also served as a director of CM Life Sciences II Inc. (Nasdaq: CMII), a special purpose acquisition company with a focus on the life sciences sector, since its initial public offering in February 2021. Dr. Kelly has a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from the Massachusetts Institute of Technology.

What is Jason R. Kelly's net worth?

The estimated net worth of Jason R. Kelly is at least $3.44 million as of January 3rd, 2024. Dr. Kelly owns 3,994,680 shares of Ginkgo Bioworks stock worth more than $3,435,824 as of April 28th. This net worth estimate does not reflect any other investments that Dr. Kelly may own. Additionally, Dr. Kelly receives a salary of $262,500.00 as Insider at Ginkgo Bioworks. Learn More about Jason R. Kelly's net worth.

How old is Jason R. Kelly?

Dr. Kelly is currently 42 years old. There are 1 older executives and no younger executives at Ginkgo Bioworks. The oldest executive at Ginkgo Bioworks is Mr. Mark E. Dmytruk, Chief Financial Officer, who is 52 years old. Learn More on Jason R. Kelly's age.

What is Jason R. Kelly's salary?

As the Insider of Ginkgo Bioworks Holdings, Inc., Dr. Kelly earns $262,500.00 per year. The highest earning executive at Ginkgo Bioworks is Mr. Mark E. Dmytruk, Chief Financial Officer, who commands a salary of $465,250.00 per year. Learn More on Jason R. Kelly's salary.

How do I contact Jason R. Kelly?

The corporate mailing address for Dr. Kelly and other Ginkgo Bioworks executives is 955 Fifth Avenue, New York NY, 10075. Ginkgo Bioworks can also be reached via phone at 877-442-5362 and via email at [email protected]. Learn More on Jason R. Kelly's contact information.

Has Jason R. Kelly been buying or selling shares of Ginkgo Bioworks?

Jason R. Kelly has not been actively trading shares of Ginkgo Bioworks within the last three months. Most recently, Jason R. Kelly sold 100,000 shares of the business's stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $1.54, for a transaction totalling $154,000.00. Following the completion of the sale, the insider now directly owns 3,994,680 shares of the company's stock, valued at $6,151,807.20. Learn More on Jason R. Kelly's trading history.

Who are Ginkgo Bioworks' active insiders?

Ginkgo Bioworks' insider roster includes Barry Canton (Major Shareholder), Marijn Dekkers (Director), Mark Dmytruk (Insider), Christian Henry (Director), Jason Kelly (Insider), and Reshma Shetty (Insider). Learn More on Ginkgo Bioworks' active insiders.

Are insiders buying or selling shares of Ginkgo Bioworks?

In the last twelve months, Ginkgo Bioworks insiders bought shares 1 times. They purchased a total of 400,000 shares worth more than $512,000.00. In the last twelve months, insiders at the sold shares 71 times. They sold a total of 3,788,984 shares worth more than $26,732,779.17. The most recent insider tranaction occured on April, 2nd when insider Mark E Dmytruk sold 51,169 shares worth more than $53,727.45. Insiders at Ginkgo Bioworks own 15.1% of the company. Learn More about insider trades at Ginkgo Bioworks.

Information on this page was last updated on 4/2/2024.

Jason R. Kelly Insider Trading History at Ginkgo Bioworks

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2024Sell100,000$1.54$154,000.003,994,680View SEC Filing Icon  
12/20/2023Sell100,000$1.79$179,000.004,194,680View SEC Filing Icon  
12/13/2023Sell99,020$1.34$132,686.804,395,660View SEC Filing Icon  
12/6/2023Sell100,000$1.32$132,000.004,594,680View SEC Filing Icon  
11/24/2023Sell100,000$1.41$141,000.004,894,680View SEC Filing Icon  
11/22/2023Sell100,000$1.40$140,000.004,994,680View SEC Filing Icon  
11/15/2023Sell100,000$1.54$154,000.005,194,680View SEC Filing Icon  
10/18/2023Sell100,000$1.69$169,000.005,994,680View SEC Filing Icon  
10/11/2023Sell100,000$1.76$176,000.006,194,680View SEC Filing Icon  
9/27/2023Sell100,000$1.82$182,000.006,594,680View SEC Filing Icon  
9/7/2023Sell100,000$2.13$213,000.007,094,680View SEC Filing Icon  
8/30/2023Sell100,000$2.21$221,000.007,394,680View SEC Filing Icon  
8/23/2023Sell100,000$1.74$174,000.007,594,680View SEC Filing Icon  
7/26/2023Sell100,000$2.38$238,000.008,394,680View SEC Filing Icon  
7/12/2023Sell100,000$2.09$209,000.008,794,680View SEC Filing Icon  
7/5/2023Sell100,000$1.81$181,000.008,994,680View SEC Filing Icon  
6/28/2023Sell100,000$1.70$170,000.009,194,680View SEC Filing Icon  
6/14/2023Sell100,000$1.95$195,000.009,594,680View SEC Filing Icon  
1/25/2023Sell258,748$1.73$447,634.0414,947,040View SEC Filing Icon  
1/23/2023Sell143,807$1.75$251,662.2515,359,782View SEC Filing Icon  
1/17/2023Sell151,531$1.86$281,847.6616,172,783View SEC Filing Icon  
1/11/2023Sell246,449$1.61$396,782.8916,734,634View SEC Filing Icon  
12/23/2022Sell203,349$1.64$333,492.3617,787,655View SEC Filing Icon  
12/19/2022Sell206,449$1.67$344,769.8318,802,367View SEC Filing Icon  
12/7/2022Sell100,909$1.69$170,536.2119,708,432View SEC Filing Icon  
11/21/2022Sell103,765$2.10$217,906.5020,519,888View SEC Filing Icon  
11/18/2022Sell98,562$2.17$213,879.5420,623,653View SEC Filing Icon  
11/16/2022Sell219,089$2.42$530,195.3820,943,617View SEC Filing Icon  
11/11/2022Sell197,964$2.65$524,604.6021,583,782View SEC Filing Icon  
11/9/2022Sell207,960$2.43$505,342.8021,967,774View SEC Filing Icon  
11/7/2022Sell205,809$2.42$498,057.7822,369,350View SEC Filing Icon  
10/24/2022Sell206,504$2.48$512,129.9223,954,637View SEC Filing Icon  
10/21/2022Sell201,371$2.44$491,345.2424,161,141View SEC Filing Icon  
10/19/2022Sell211,829$2.50$529,572.5024,559,233View SEC Filing Icon  
10/13/2022Sell207,271$2.74$567,922.5425,380,378View SEC Filing Icon  
See Full Table

Jason R. Kelly Buying and Selling Activity at Ginkgo Bioworks

This chart shows Jason R Kelly's buying and selling at Ginkgo Bioworks by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ginkgo Bioworks Company Overview

Ginkgo Bioworks logo
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $0.86
Low: $0.76
High: $0.87

50 Day Range

MA: $1.13
Low: $0.78
High: $1.54

2 Week Range

Now: $0.86
Low: $0.74
High: $2.55

Volume

71,222,534 shs

Average Volume

31,559,994 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35